Moreover, in RA patients, receiving treatment with anti‐TNF therapy for the underlying rheumatic disease was significantly associated with lower odds of COVID‐19‐related hospitalization, in contrast to not receiving any anti‐TNF inhibitor therapy.33 This evidence concerns the gene TNF and rheumatic disorder.